Effect of N-n-butyl haloperidol iodide on ROS/JNK/Egr-1 signaling in H9c2 cells after hypoxia/reoxygenation

Scientific Reports

Volumn 5, Issue 1, 2015, Pages

  Zhang, Yanmei ^a   Liao, Han ^a   Zhong, Shuping ^b   Gao, Fenfei ^a   Chen, Yicun ^a   Huang, Zhanqin ^a   Lu, Shishi ^a   Sun, Ting ^a   Wang, Bin ^a   Li, Weiqiu ^a   Xu, Han ^a   Zheng, Fuchun ^a   Shi, Ganggang ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN; HALOPERIDOL; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; N-N-BUTYL HALOPERIDOL IODIDE; PHENAZONE; PHENYLMETHYLPYRAZOLONE; REACTIVE OXYGEN METABOLITE; XANTHINE OXIDASE;

ANALOGS AND DERIVATIVES; BIOSYNTHESIS; CARDIAC MUSCLE CELL; CELL HYPOXIA; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; ANTIPYRINE; CELL HYPOXIA; CELL LINE; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; HALOPERIDOL; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; XANTHINE OXIDASE;

EID: 85018221808     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/SREP11809     Document Type: Article

References (32)

1. Murphy, E. & Steenbergen, C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 88, 581–609 (2008).
2. Pagel, J. I. & Deindl, E. Disease progression mediated by egr-1 associated signaling in response to oxidative stress. Int J Mol Sci. 13, 13104–13117 (2012).
3. Minamino, T. Cardioprotection from ischemia/reperfusion injury: basic and translational research. Circ J. 76, 1074–1082 (2012).
4. Madureira, P. A. & Waisman, D. M. Annexin A2: the importance of being redox sensitive. Int J Mol Sci. 14, 3568–3594 (2013).
5. Cosentino-Gomes, D., Rocco-Machado, N. & Meyer-Fernandes, J. R. Cell Signaling through Protein Kinase C Oxidation and Activation. Int J Mol Sci. 13, 10697–10721 (2012).
6. Choudhury, S., Panda, P., Sahoo, L. & Panda, S. K. Reactive oxygen species signaling in plants under abiotic stress. Plant signal Beha. 8, e23681 (2013).
7. Kaufmann, K. & Thiel, G. Epidermal growth factor and thrombin induced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J Cell Biochem. 85, 381–391 (2002).
8. Grohe, C., Nouskas, J., Vetter, H. & Neyses, L. Effects of nisoldipine on endothelin-1-and angiotensin II-induced immediate/ early gene expression and protein synthesis in adult rat ventricular cardiomyocytes. J Cardiovas Pharmacol. 24, 13–16 (1994).
9. Yan, S. F. et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med. 6, 1355–1361 (2000).
10. Zhang, Y. et al. The protective effects of N-n-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rats by inhibiting Egr-1 overexpression. Cell Physiol Biochemi. 20, 639–648 (2007).
11. Zhang, Y. et al. The protective effect of Egr-1 antisense oligodeoxyribonucleotide on myocardial injury induced by ischemia-reperfusion and hypoxia-reoxygenation. Cell Physiol Biochemi. 22, 645–652 (2008).
12. Wang, J. Z. et al. N-n-Butyl haloperidol iodide protects against hypoxia/reoxygenation-induced cardiomyocyte injury by modulating protein kinase C activity. Biochem Pharmacol. 79, 1428–1436 (2010).
13. Gao, F. F. et al. Cardiac electrophysiological and antiarrhythmic effects of N-n-butyl haloperidol iodide. Cell Physiol Biochemi. 25, 433–442 (2010).
14. Zhang, Y. et al. N-n-butyl haloperidol iodide ameliorates cardiomyocytes hypoxia/reoxygenation injury by extracellular calcium-dependent and-independent mechanisms. Oxid Med Cell Longevi. 2013, 912310 (2013).
15. Huang, Z. et al. Egr-1, the potential target of calcium channel blockers in cardioprotection with ischemia/reperfusion injury in rats. Cell Physiol Biochemi. 24, 17–24 (2009).
16. Lamb, R. E. & Goldstein, B. J. Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function. Int J Clin Pract. 62, 1087–1095 (2008).
17. Mkaddem, S. B., Bens, M. & Vandewalle, A. Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia. Oncotarget 1, 741–750 (2010).
18. Sun, K. H., Lee, H. G., Smith, M. A. & Shah, K. Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer’s disease. Mol Biol Cell. 20, 4611–4619 (2009).
19. Saben, J. et al. Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity. Am J Physiol Endocrinol Metab. 305, E1–14 (2013).
20. Choi, S., Na, H. Y., Kim, J. A., Cho, S. E. & Suh, S. H. Contradictory Effects of Superoxide and Hydrogen Peroxide on KCa3.1 in Human Endothelial Cells. Korean J Physiol Pharmacol. 17, 181–187 (2013).
21. Kelley, E. E. et al. Hydrogen peroxide is the major oxidant product of xanthine oxidase. Free Radic Biol Med. 48, 493–498 (2010).
22. Han, J., Shuvaev, V. V. & Muzykantov, V. R. Catalase and superoxide dismutase conjugated with platelet-endothelial cell adhesion molecule antibody distinctly alleviate abnormal endothelial permeability caused by exogenous reactive oxygen species and vascular endothelial growth factor. J Pharmacol Exp Ther. 338, 82–91 (2011).
23. Jeong, S. H. et al. ZnO nanoparticles induce TNF-alpha expression via ROS-ERK-Egr-1 pathway in human keratinocytes. J Dermatol Sci. 72, 263–273 (2013).
24. Han, M. H. et al. Apoptosis induction of human bladder cancer cells by sanguinarine through reactive oxygen species-mediated up-regulation of early growth response gene-1. PloS one 8, e63425 (2013).
25. Han, M. H., Kim, G. Y., Yoo, Y. H. & Choi, Y. H. Sanguinarine induces apoptosis in human colorectal cancer HCT-116 cells through ROS-mediated Egr-1 activation and mitochondrial dysfunction. Toxicol Lett. 220, 157–166 (2013).
26. Jeon, H. M. et al. Early growth response 1 regulates glucose deprivation-induced necrosis. Oncol Rep. 29, 669–675 (2013).
27. Aggeli, I. K., Beis, I. & Gaitanaki, C. ERKs and JNKs mediate hydrogen peroxide-induced Egr-1 expression and nuclear accumulation in H9c2 cells. Physiol Res. 59, 443–454 (2010).
28. Hartney, T. et al. Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia. PloS one 6, e27531 (2011).
29. Nozik-Grayck, E. et al. Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling. Am J Physiol Lung cell Mol Physiol. 295, L422–430 (2008).
30. Mo, Y. et al. Combination effects of cigarette smoke extract and ambient ultrafine particles on endothelial cells. Toxicol In vitro. 26, 295–303 (2012).
31. Thiel, G., Mayer, S. I., Muller, I., Stefano, L. & Rossler, O. G. Egr-1-A Ca(2+)-regulated transcription factor. Cell calcium 47, 397–403 (2010).
32. Zhang, Y. M. et al. Effects of N-n-butyl haloperidol iodide on myocardial ischemia/reperfusion injury and Egr-1 expression in rat. Acta Biochim Biophys Sin. 38, 435–441 (2006).